Latest Financial Reports News

ECS Botanics reports a 5% revenue dip to $19.5 million in FY25 but sees strong B2C growth and record harvest volumes, offset by non-cash impairments.

Motio Limited has reported a remarkable financial turnaround for the year ended June 30, 2025, with profit after tax more than doubling and Cash EBITDA soaring by 291%. Despite these gains, the company has opted not to declare a dividend.

Resonance Health Limited reported a 29% revenue increase to $11.07 million for FY25 but posted a net loss of $1.73 million, reflecting strategic investments and expansion in clinical trial services.

Jupiter Mines Limited reported a modest rise in net profit to $40.1 million for FY2025, supported by strong joint venture earnings and increased marketing fees. The company declared a final dividend as manganese prices stabilized after early-year volatility.

Change Financial Limited reported a robust FY25 with 42% revenue growth and its first full-year positive underlying EBITDA, driven by strong PaaS expansion and strategic exit from the US market. The company projects further growth and profitability in FY26.

Austal Limited has reported a remarkable 24% revenue increase and a 503% surge in net profit for FY2025, yet has chosen not to declare any dividends for the year.

Echelon Resources Limited reported a robust financial year ending June 2025, driven by strategic asset acquisitions and strong commodity prices, delivering a 34% revenue increase and a near 20-fold jump in net profit after tax.

Atlas Pearls Ltd has declared a fully franked 1.4 cent per share dividend for the second half of FY25, lifting total dividends for the year to 2.4 cents, up from 1.85 cents in FY24.

BDO Audit has completed its review of HeraMED Limited’s half-year financial report for June 2025, confirming compliance with accounting standards but highlighting significant uncertainty over the company’s ability to continue as a going concern.

Cynata Therapeutics reported a $9.39 million net loss for FY2025, slightly improved from the prior year, while progressing multiple clinical trials with key results expected in 2026. The company maintains a solid cash position and funding runway through mid-2026, supported by recent capital raises and an equity subscription agreement.

Steadfast Group Limited has announced a fully franked ordinary dividend of AUD 0.117 per share for the half-year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 2.5% discount.

Glennon Small Companies Limited reported a robust FY25 with a 232.75% jump in net profit and declared final dividends, while strategically resetting its preference shares amid evolving small-cap market dynamics.